- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Alirocumab – March 2019
Alirocumab: Injection 75 mg in 1 mL single dose pre-filled pen, Injection 150 mg in 1 mL single dose pre-filled pen; Praluent®
Last updated
5 July 2019